Rofecoxib
- Generic Name
- Rofecoxib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H14O4S
- CAS Number
- 162011-90-7
- Unique Ingredient Identifier
- 0QTW8Z7MCR
- Background
Rofecoxib is used for the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine attacks with or without auras. Rofecoxib is a solid. This compound belongs to the stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived...
- Indication
For the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine attacks with or without auras.
- Associated Conditions
- -
- Associated Therapies
- -
Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
- Conditions
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 150
- Registration Number
- NCT00026819
- Locations
- 🇺🇸
National Institute of Dental And Craniofacial Research (NIDCR), Bethesda, Maryland, United States
A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
- Conditions
- First Posted Date
- 2000-02-29
- Last Posted Date
- 2009-12-11
- Lead Sponsor
- National Institute on Aging (NIA)
- Registration Number
- NCT00004845
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸Medical University of South Carolina, North Charleston, South Carolina, United States
🇺🇸University of California Irvine Institute for Brain Aging and Dementia, Irvine, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.